Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singular Health GroupASX:SHG -2.63%26 Equity-to-Asset is 0.93 as of Dec. 2025, which is 12% above its 10-year median of 0.83. GuruFocus rates ASX:SHG with a GF Score™ of 26/100 and a GF Value™ of A$0.11 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Singular Health Group ranks better than 97.66% on this metric.
The historical rank and industry rank for Singular Health Group's Equity-to-Asset or its related term are showing as below:
ASX:SHG'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.02 Med: 0.83 Max: 0.94
Current: 0.93
During the past 5 years, the highest Equity to Asset Ratio of Singular Health Group was 0.94. The lowest was -0.02. And the median was 0.83.
ASX:SHG's Equity-to-Asset is ranked better than 97.66% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs ASX:SHG: 0.93
Singular Health Group (ASX:SHG) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Singular Health Group Equity-to-Asset Related Terms
Singular Health Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Singular Health Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:SHG vs VEEV, BTSG, HQY: Equity-to-Asset Comparison
For the Health Information Services subindustry, Singular Health Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singular Health Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Singular Health Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Singular Health Group's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Singular Health Group's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Health Group (ASX:SHG) has a Equity-to-Asset of 0.93 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Singular Health Group and its competitors. This is 12% above median its historical median of 0.83. According to the industry distribution chart, Singular Health Group ranks #16 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 2.3%.
Is Singular Health Group's Equity-to-Asset too high?
Singular Health Group's current Equity-to-Asset of 0.93 is 12% above median its 10-year median of 0.83. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Singular Health Group's value of 0.93 is 93.8% above this industry median. Based on the distribution chart, Singular Health Group ranks #16 out of 685 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Singular Health Group has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's Equity-to-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Singular Health Group ranks #16 out of 685 companies for Equity-to-Asset. This places Singular Health Group in the top 2% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.48. Singular Health Group's value of 0.93 is 93.8% above this benchmark. While the company's 10-year median is 0.83 vs. the industry median of 0.48, Singular Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Singular Health Group's current Equity-to-Asset of 0.93 is 93.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Singular Health Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singular Health Group's current Equity-to-Asset is 0.93, which is 12% above median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.19 — trading 68.2% above its estimated fair value. The current Equity-to-Asset is 0.93, which is 12% above median its 10-year median of 0.83 and 93.8% above the Healthcare Providers & Services industry median of 0.48. Singular Health Group's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current Equity-to-Asset is 0.93 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Singular Health Group (ASX:SHG) Overvalued in 2026?
Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued.
The current stock price of A$0.19 is trading 68.2% above its estimated GF Value™ of A$0.11.
GuruFocus considers Singular Health Group to be Significantly Overvalued.
Key valuation signals for ASX:SHG:
Equity-to-Asset: 0.93 (12% above median its 10-year median of 0.83)
GF Value™: A$0.11 vs. price of A$0.19 (68.2% above fair value)
Industry Position: 93.8% above the Healthcare Providers & Services median (#16 of 685)
No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
26GF Score
Get the complete analysis for ASX:SHG
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SHG has been successfully added to your 
